With the rise of biologics, precision medicine and AI-driven drug discovery, clinical research has entered a new and complex ...

The global clinical laboratory test market has been segmented based on types of laboratories, application, types of tests, and end-users. On the basis of types of laboratories, the market for clinical ...

Labroots is excited to announce the 15th Annual Event in the Clinical Diagnostics & Research Virtual Event Series on November 13th, 2024! This event will again bring together clinicians, researchers, ...

This article is the third in Microbiologics’ series on Optimal QC in the Clinical Laboratory. Previously, in this series we highlighted the importance of external and third-party quality control ...

Labcorp, currently in the midst of a corporate shakeup aimed at turning its focus to the offerings that make it one of the largest providers of laboratory and diagnostics services in the life sciences ...

In the realm of molecular diagnostics, new research highlights developments made by sequencing the DNA of pediatric cancer patients and links specific sequences to tumor risk. A perspective article ...

Avinasi Labs Enables a New Funding & Revenue Model for Clinical Stage Assets via DeLong Protocol SAN FRANCISCO, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — Avinasi Labs, an AI-native ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The addition will help the ...

The UC Santa Cruz Colligan Clinical Diagnostic Laboratory (CCDL) has received its CLIA certificate of registration from the California Department of Public Health, which clears the way for it to begin ...

The Clinical Exercise Physiology Laboratory is dedicated to studying the physiological effects of physical activity to enhance human health and well-being. The lab conducts projects examining the ...

Fred Hutch Cancer Center researchers are studying ways to prevent prostate cancer, including lifestyle choices that can lower risk. They also seek better methods to screen for the disease, tell which ...

The ruling means the NIH will continue to pay indirect cost rates, which fund labs, infrastructure and utilities.